Corporate Banner
Satellite Banner
Mass Spectrometry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Article on the Dangers of Chloramphenicol in Milk and Its Detection

Published: Tuesday, July 02, 2013
Last Updated: Tuesday, July 02, 2013
Bookmark and Share
An article exploring the dangers posed by chloramphenicol (CAP) in milk and its detection using the EVOQ Qube LC-TQ MS/MS is described.

The article entitled “The Danger of Chloramphenicol in Milk” from the Bruker Chemical & Applied Markets (CAM) division has been published in Food Safety Magazine online. Authored by Bruker specialists in liquid chromatography, the article examines the dangerous effects of CAP in contaminated food and how the high sensitivity EVOQ can detect levels as low as 0.02 ppb in milk, far exceeding minimum required performance levels (MRPL) set by EU guidelines.
 
Chloramphenicol is a naturally occurring broad spectrum antibiotic, initially employed as a first line of treatment for typhoid. Although CAP is still commonly prescribed as an optical treatment in the EU, its use is otherwise severely limited. This is in part due to the risk the drug poses to infants, who lack the fully developed liver enzymes to metabolize the drug. Ingestion of CAP can thus cause potentially fatal Gray Baby syndrome, and has also been linked to acute lymphotic leukemia and bone marrow suppression.
 
Consequently in the EU chloramphenicol is banned from use in veterinary medicine and its presence in food products such as milk is strictly prohibited. Regulations state that methods used for the detection of CAP in milk must meet or exceed the MRPL of 0.3 ppb. A case study was carried out on the EVOQ Qube LC-TQ MS/MS, designed for maximum sensitivity in high throughput applications. The EVOQ was able to quantify concentrations as low as 0.2 ppb, easily exceeding EU guidelines, while maintaining consistent ion rations from 0.05 to 1.0 ppb.
 
“Routine food testing requires sustained high sensitivity and the fastest possible turnaround, since time can be critical,” Meredith Conoley, Marketing Director for Bruker CAM, said. “The EVOQ was specifically designed with new technological innovations to meet these criteria. The Active Exhaust prevents the recirculation of nebulized gases to reduce chemical build up, while the Orifice Interface is continually flushed to keep it clean and reduce instrument downtime. PACER exception based data review software moreover provides the fastest sample to report time possible. This high performance instrument offers advantages for many application areas, including environmental testing and forensics.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
New ACE-inhibiting Molecule Found in the Asparagus
Scientists have determined that sulfur-containing compounds in plants can inhibit ACE.
The Linking of Molecules and Microbes
Researchers have succeeded in making antibiotic substances and their bacterial producers simultaneously visible.
PTR-MS Breath Test Shows Potential for Detecting Liver Disease
Researchers at the University of Birmingham have published results that suggest a non-invasive breath test for liver disease using an IONICON PTR-MS.
New Test Could Distinguish Between Bipolar Disorder, Depression
Scientists are developing a test that could tell the difference between bipolar disorder and depression.
Early Detection of Lung Cancer
The University of Manchester has signed a collaboration agreement with Abcodia to perform proteomics studies on a cohort of non-small cell lung cancer cases from the UKCTOCS biobank, with the aim of discovering new blood-based biomarkers for earlier detection of the disease.
Detecting Hidden Ingredients
Researchers from China have used mass spectrometry to reveal the use of undeclared substances in dietary supplements.
How the Lung Repairs its Wounds
Researchers have gained detailed insights into the dynamic remodeling of the tissue during lung repair.
Automation Abound at AACC in Atlanta
Discover the latest breakthroughs, trends and products from the AACC Annual Meeting & Clinical Lab Expo.
Could a simple saliva test detect Alzheimer's?
Researchers have presented findings suggesting that a simple, non-invasive diagnostic for Alzheimer's could be within reach.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!